Allergy Therapeutics (AGY)

London
35.50
-0.50(-1.39%)
  • Volume:
    236,198
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    36.00 - 36.00

AGY Overview

Prev. Close
36
Day's Range
36-36
Revenue
84.33M
Open
36.75
52 wk Range
12.4-39
EPS
0
Volume
236,198
Market Cap
231.05M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
388,246
P/E Ratio
115.02
Beta
1.45
1-Year Change
140%
Shares Outstanding
641,798,718
Next Earnings Date
-
What is your sentiment on Allergy Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Allergy Therapeutics News

Allergy Therapeutics Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellNeutralStrong Buy
Technical IndicatorsNeutralSellStrong SellSellStrong Buy
SummaryNeutralSellStrong SellNeutralStrong Buy

Allergy Therapeutics Company Profile

Allergy Therapeutics Company Profile

Employees
0

Allergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.

Read More
  • Am buying tomorrow .( .there might be some good news coming )
    1
    • Am buying tomorrow .( ..near might be some good news coming )
      1
      • it a good time to sell
        1
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.